Search academic texts

Information × Registration Number 0120U104536, R & D request Title Promising randomized multicenter open-label comparative phase 3 study conducted in parallel groups with central evaluation blindness to determine the efficacy, safety, and tolerability of the aztreon-avibactam (ATM-AVI) combination of metronidazole (MTZ) versus meropenemOL colistin (MER) for the treatment of serious infections caused by gram-negative bacteria, including multicomponent drug-resistant lactose-producing pathogens (MBL), for which treatment options are limited or absent Head Kaidashev Ihor P., д.мед.н. Registration Date 23-10-2020 Organization Ukrainian medical stomatological Academy popup.description1 tudy conducted in parallel groups with central evaluation blindness to determine the efficacy, safety, and tolerability of the aztreon-avibactam (ATM-AVI) combination of metronidazole (MTZ) versus meropenemOL colistin (MER) for the treatment of serious infections caused by gram-negative bacteria, including multicomponent drug-resistant lactose-producing pathogens (MBL), for which treatment options are limited or absent popup.nrat_date 2024-12-10 Close